Categories
World

Global Nanoemulsion Market Is Expected To Reach US$ 14,760.4 Mn During The Forecast Period 2018 – 2026

According to the latest report published by Acute Market Reports “Nanoemulsion Market – Growth, Future Prospects and Competitive Analysis, 2018-2026,” the nanoemulsion market was valued at USD 6,827.5 Mn in 2017, and is expected to reach USD 14,760.4 Mn by 2026, expanding at a CAGR of 8.9% from 2018 to 2026.

Market Insights

Nanoemusions are sub-micron sized emulsions that act as drug carriers to improve the therapeutic effect and delivery of the drug. Nanoemulsions are of three types O/W nanoemulsion, W/O nanoemulsion, and Bi-continuous nanoemulsion. In pharmaceutical industries nanoemulsions have exhibited huge potential with its transparency at high droplet volume fraction, improved diffusion or bioavailability and enhances shelf life of drugs. There are wide applications of nanoemulsion such as antimicrobials, mucosal vaccines, non-toxic disinfectant cleaner, cell culture technology, vehicle for transdermal delivery, osteoarthritis treatment, and targeted drug delivery in cancer. The advantages possessed by nanoemulsion formulations are delivery of therapeutic or diagnostic agents, controlled drug release, high solubility of drug, improved bioavailability, and decrease in patient variability. Thus, ongoing research in the field of nanoemulsions is expected to assist the growth of overall nanoemulsion market in the near future.

Browse the full report Nanoemulsion Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 at  https://www.acutemarketreports.com/report/nanoemulsion-market

The nanoemulsion market is segmented on the basis of route of administration and application. The routes of administration covered in this report comprise topical, ocular, intravenous, intranasal, and oral delivery. The applications of nanoemulsion are antimicrobial, cosmetic, oncology, prophylactic in bioterrorism, mucosal vaccines, cell culture technology, non-toxic disinfectants, gene delivery vector, and drug delivery route enhancement.

In 2017, topical and intravenous collectively accounted around 50% of the global share in nanoemulsion market due to factors such as enhancement in drug delivery, and rapid absorption in systemic circulation. Nanoemulsion provides major advantages in the formulation of hydrophobic molecules by enhancing their solubility and further resulting in improved bioavailability. Estranob (oestradiol hemihydrate) manufactured by Novavax Inc. contains oestradiol hemihydrate in a nanoemulsion comprising soybean oil, polysorbate 80, water, and ethanol, used in management of vasomotor indications related to menopause. Thus, nanoemulsion based topical & intravenous route of drug delivery dominated the market and these segments are expected to maintain their dominance throughout the forecast period.

North America was observed as the largest nanoemulsion market due to key factors such as rising demand for enhanced drug delivery technologies, incessant development in nanotechnology, high awareness related to early disease diagnosis. Technologically North America evolves rapidly and easy access towards latest treatment makes it largest market globally. In March 2018, Therapeutics Solutions International, Inc., based in the U.S successfully produced a stable nanoemulsion of pterostilbene from ingredients Generally Regarded as Safe (GRAS). This nanoemulsion, which is a form of pterostilbene containing nanoparticles used in cancer immunotherapy and the brand name of this product is ProJuvenol. Thus, technological development in the field of nanoemulsions is significantly growing in North America. During the forecast period 2018 to 2026, Asia Pacific is expected to grow at a significant rate due rising demand for effective drug formulations, developing healthcare infrastructure, and increasing awareness related to disease diagnosis & treatment.

Market Competition Assessment:

The nanoemulsion market is one of the fastest growing pharmaceutical formulation technology market with presence several established and upcoming players. The key players operating in this market are AbbVie Inc., Allergan plc, AstraZeneca plc, Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., Covaris, Inc., NanoBio Corporation, Novartis AG, GlaxoSmithKline plc, and Sanofi S.A. among others.

Key Market Movements:

• Nanoemulsion technology is gaining momentum these years due to its multiple advantages and wide applications
• Increasing demand for targeted drug delivery is assisting the growth of nanoemulsion market
• Innovation and constructive developments in the field of formulation enhancement is expected to assist the overall market growth of nanoemulsion
• The pipeline is strong there are several clinical trials that are being carried out with nanoemulsion for enhancing the therapeutic effect of drug

The Global Nanoemulsion Market is Segmented into:

ATTRIBUTE DETAILS
Research Period  2016-2026
Base Year 2017
Forecast Period  2018-2026
Historical Year  2016
Unit  USD Million
Segmentation

 Route of Administration Type Segment (2016–2026; US$ Mn)

 Application Segment (2016-2026; US$ Mn)

 Geography Segment (2016–2026; US$ Mn)

*Complete segmentation list is on report page

 

Key questions answered in this report

  • What are the current market trends and dynamics in the nanoemulsion market and valuable opportunities for emerging players?
  • Estimated forecast and market projections up to 2029
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which is the largest regional market for nanoemulsion?
  • What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • The worldwide market value of the nanoemulsion market in 2019 and 2020
  • Which are the key trends driving the global nanoemulsion market growth?
  • Who are the leading service providers in the nanoemulsion market worldwide?

About Acute Market Reports

Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Contact Info.:-

Address: 90 Church St, FL 1 #3514,
New York, NY 10008
United States
Email: [email protected]
Toll Free(US/CANADA): +1-855-455-8662
Website: https://www.acutemarketreports.com

https://tramways-monthly.com/